CUSIP No. 140755109
|
Schedule 13G
|
Page 2 of 12
|
1
|
NAME OF REPORTING PERSONS
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
Ascent Biomedical Ventures I, L.P.
|
|||
2
|
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions)
(a) o
(b) x
|
|
||
3
|
SEC USE ONLY
|
|||
4
|
CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
|
|||
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON
WITH
|
5
|
SOLE VOTING POWER
Not applicable
|
||
6
|
SHARED VOTING POWER
963,896
|
|||
7
|
SOLE DISPOSITIVE POWER
Not applicable
|
|||
8
|
SHARED DISPOSITIVE POWER
963,896
|
|||
9
|
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
963,896
|
|||
10
|
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (See Instructions)
|
x (1)
|
||
11
|
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
4.2%
|
|||
12
|
TYPE OF REPORTING PERSON (See Instructions)
PN
|
CUSIP No. 140755109
|
Schedule 13G
|
Page 3 of 12
|
1
|
NAME OF REPORTING PERSONS
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
Ascent Biomedical Ventures I Annex, L.P.
|
|||
2
|
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions)
(a) o
(b) x
|
|
||
3
|
SEC USE ONLY
|
|||
4
|
CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
|
|||
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON
WITH
|
5
|
SOLE VOTING POWER
Not applicable
|
||
6
|
SHARED VOTING POWER
131,169
|
|||
7
|
SOLE DISPOSITIVE POWER
Not applicable
|
|||
8
|
SHARED DISPOSITIVE POWER
131,169
|
|||
9
|
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
131,169
|
|||
10
|
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (See Instructions)
|
x (2)
|
||
11
|
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
0.6%
|
|||
12
|
TYPE OF REPORTING PERSON (See Instructions)
PN
|
CUSIP No. 140755109
|
Schedule 13G
|
Page 4 of 12
|
1
|
NAME OF REPORTING PERSONS
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
Ascent Biomedical Ventures I NY, L.P.
|
|||
2
|
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions)
(a) o
(b) x
|
|
||
3
|
SEC USE ONLY
|
|||
4
|
CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
|
|||
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON
WITH
|
5
|
SOLE VOTING POWER
Not applicable
|
||
6
|
SHARED VOTING POWER
604,428
|
|||
7
|
SOLE DISPOSITIVE POWER
Not applicable
|
|||
8
|
SHARED DISPOSITIVE POWER
604,428
|
|||
9
|
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
604,428
|
|||
10
|
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (See Instructions)
|
x (3)
|
||
11
|
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
2.7%
|
|||
12
|
TYPE OF REPORTING PERSON (See Instructions)
PN
|
CUSIP No. 140755109
|
Schedule 13G
|
Page 5 of 12
|
1
|
NAME OF REPORTING PERSONS
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
ABV, LLC
|
|||
2
|
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions)
(a) o
(b) x
|
|
||
3
|
SEC USE ONLY
|
|||
4
|
CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
|
|||
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON
WITH
|
5
|
SOLE VOTING POWER
Not applicable
|
||
6
|
SHARED VOTING POWER
1,699,493 (4)
|
|||
7
|
SOLE DISPOSITIVE POWER
Not applicable
|
|||
8
|
SHARED DISPOSITIVE POWER
1,699,493 (4)
|
|||
9
|
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
1,699,493 (4)
|
|||
10
|
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (See Instructions)
|
x (5)
|
||
11
|
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
7.5%
|
|||
12
|
TYPE OF REPORTING PERSON (See Instructions)
OO
|
CUSIP No. 140755109
|
Schedule 13G
|
Page 6 of 12
|
1
|
NAME OF REPORTING PERSONS
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
Geoffrey W. Smith
|
|||
2
|
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions)
(a) o
(b) x
|
|
||
3
|
SEC USE ONLY
|
|||
4
|
CITIZENSHIP OR PLACE OF ORGANIZATION
United States
|
|||
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON
WITH
|
5
|
SOLE VOTING POWER
Not applicable
|
||
6
|
SHARED VOTING POWER
1,699,493 (6)
|
|||
7
|
SOLE DISPOSITIVE POWER
Not applicable
|
|||
8
|
SHARED DISPOSITIVE POWER
1,699,493 (6)
|
|||
9
|
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
1,699,493 (6)
|
|||
10
|
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (See Instructions)
|
x (7)
|
||
11
|
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
7.5%
|
|||
12
|
TYPE OF REPORTING PERSON (See Instructions)
IN
|
CUSIP No. 140755109
|
Schedule 13G
|
Page 7 of 12
|
1
|
NAME OF REPORTING PERSONS
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
Steve Hochberg
|
|||
2
|
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions)
(a) o
(b) x
|
|
||
3
|
SEC USE ONLY
|
|||
4
|
CITIZENSHIP OR PLACE OF ORGANIZATION
United States
|
|||
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON
WITH
|
5
|
SOLE VOTING POWER
Not applicable
|
||
6
|
SHARED VOTING POWER
1,699,493 (8)
|
|||
7
|
SOLE DISPOSITIVE POWER
Not applicable
|
|||
8
|
SHARED DISPOSITIVE POWER
1,699,493 (8)
|
|||
9
|
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
1,699,493 (8)
|
|||
10
|
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (See Instructions)
|
x (9)
|
||
11
|
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
7.5%
|
|||
12
|
TYPE OF REPORTING PERSON (See Instructions)
IN
|
CUSIP No. 140755109
|
Page 8 of 12
|
(a)
|
Name of Issuer:
|
(b)
|
Address of Issuer’s Principal Executive Offices:
|
(a)
|
Name of Person Filing:
|
|
(i)
|
Ascent Biomedical Ventures I, L.P. (“Ascent”)
|
|
(ii)
|
Ascent Biomedical Ventures I Annex, L.P. (“Ascent Annex”)
|
|
(iii)
|
Ascent Biomedical Ventures I NY, L.P. (“Ascent NY”)
|
|
(iv)
|
ABV, LLC (“ABV”)
|
|
(v)
|
Geoffrey W. Smith (“Geoffrey Smith”)
|
|
(vi)
|
Steve Hochberg (“Steve Hochberg” and together with Ascent, Ascent Annex, Ascent NY, ABV, and Geoffrey Smith, the “Reporting Persons”)
|
(b)
|
Address of Principal Business Office or, if none, Residence:
|
|
(i)
|
142 West 57th Street, 4A, New York, NY 10019
|
|
(ii)
|
142 West 57th Street, 4A, New York, NY 10019
|
|
(iii)
|
142 West 57th Street, 4A, New York, NY 10019
|
|
(iv)
|
142 West 57th Street, 4A, New York, NY 10019
|
|
(v)
|
142 West 57th Street, 4A, New York, NY 10019
|
|
(vi)
|
142 West 57th Street, 4A, New York, NY 10019
|
(c)
|
Citizenship:
|
|
(i)
|
Delaware limited liability partnership
|
|
(ii)
|
Delaware limited liability partnership
|
|
(iii)
|
Delaware limited liability partnership
|
|
(iv)
|
Delaware limited liability company
|
|
(v)
|
United States Citizen
|
|
(vi)
|
United States Citizen
|
CUSIP No. 140755109
|
Page 9 of 12
|
(d)
|
Title of Class of Securities:
|
(e)
|
CUSIP Number:
|
(a)
|
Amount Beneficially Owned**:
|
(b)
|
Percent of Class**:
|
(c)
|
Number of shares as to which the person has**:
|
CUSIP No. 140755109
|
Page 10 of 12
|
|
Not applicable.
|
CUSIP No. 140755109
|
Page 11 of 12
|
ASCENT BIOMEDICAL VENTURES I, L.P. | ||||
By: | ABV, LLC | |||
its general partner | ||||
/s/ Steve Hochberg | ||||
Signature | ||||
Director | ||||
Name/Title | ||||
ASCENT BIOMEDICAL VENTURES I ANNEX, L.P. | ||||
By: | ABV, LLC | |||
its general partner1 | ||||
/s/ Steve Hochberg | ||||
Signature | ||||
Director | ||||
Name/Title | ||||
ASCENT BIOMEDICAL VENTURES I NY, L.P. | ||||
By: | ABV, LLC | |||
its general partner1 | ||||
/s/ Steve Hochberg | ||||
Signature | ||||
Director | ||||
Name/Title | ||||
ABV, LLC | ||||
/s/ Steve Hochberg | ||||
Signature | ||||
Director | ||||
Name/Title | ||||
CUSIP No. 140755109
|
Page 12 of 12
|
GEOFFREY W. SMITH1 | ||||
/s/ Geoffrey W. Smith | ||||
Signature | ||||
STEVE HOCHBERG1 | ||||
/s/ Steve Hochberg | ||||
Signature | ||||